242 related articles for article (PubMed ID: 21354554)
1. Orthopaedic gene therapy using recombinant adeno-associated virus vectors.
Ke J; Zheng LW; Cheung LK
Arch Oral Biol; 2011 Jul; 56(7):619-28. PubMed ID: 21354554
[TBL] [Abstract][Full Text] [Related]
2. The use of recombinant adeno-associated virus for skeletal gene therapy.
Dai J; Rabie AB
Orthod Craniofac Res; 2007 Feb; 10(1):1-14. PubMed ID: 17284242
[TBL] [Abstract][Full Text] [Related]
3. Recombinant adeno-associated virus derived vectors (rAAV2) efficiently transduce ovarian and hepatocellular carcinoma cells--implications for cancer gene therapy.
Małecki M; Swoboda P; Pachecka J
Acta Pol Pharm; 2009; 66(1):93-9. PubMed ID: 19226976
[TBL] [Abstract][Full Text] [Related]
4. Receptor targeting of adeno-associated virus vectors.
Büning H; Ried MU; Perabo L; Gerner FM; Huttner NA; Enssle J; Hallek M
Gene Ther; 2003 Jul; 10(14):1142-51. PubMed ID: 12833123
[TBL] [Abstract][Full Text] [Related]
5. Recombinant adeno-associated virus (rAAV) vectors for somatic gene therapy: recent advances and potential clinical applications.
Hallek M; Wendtner CM
Cytokines Mol Ther; 1996 Jun; 2(2):69-79. PubMed ID: 9384691
[TBL] [Abstract][Full Text] [Related]
6. Recombinant adeno-associated virus type 2 mediates highly efficient gene transfer in regenerating rat skeletal muscle.
Abadie J; Blouin V; Guigand L; Wyers M; Cherel Y
Gene Ther; 2002 Aug; 9(15):1037-43. PubMed ID: 12101435
[TBL] [Abstract][Full Text] [Related]
7. Enhanced transduction of mouse bone marrow-derived dendritic cells by repetitive infection with self-complementary adeno-associated virus 6 combined with immunostimulatory ligands.
Aldrich WA; Ren C; White AF; Zhou SZ; Kumar S; Jenkins CB; Shaw DR; Strong TV; Triozzi PL; Ponnazhagan S
Gene Ther; 2006 Jan; 13(1):29-39. PubMed ID: 16136165
[TBL] [Abstract][Full Text] [Related]
8. Progress in the use of adeno-associated viral vectors for gene therapy.
Büning H; Braun-Falco M; Hallek M
Cells Tissues Organs; 2004; 177(3):139-50. PubMed ID: 15388988
[TBL] [Abstract][Full Text] [Related]
9. Development of recombinant adeno-associated virus vectors carrying small interfering RNA (shHec1)-mediated depletion of kinetochore Hec1 protein in tumor cells.
Li L; Yang L; Scudiero DA; Miller SA; Yu ZX; Stukenberg PT; Shoemaker RH; Kotin RM
Gene Ther; 2007 May; 14(10):814-27. PubMed ID: 17330085
[TBL] [Abstract][Full Text] [Related]
10. Adeno-associated virus vectorology, manufacturing, and clinical applications.
Grieger JC; Samulski RJ
Methods Enzymol; 2012; 507():229-54. PubMed ID: 22365777
[TBL] [Abstract][Full Text] [Related]
11. Self-complementary adeno-associated virus 2 (AAV)-T cell protein tyrosine phosphatase vectors as helper viruses to improve transduction efficiency of conventional single-stranded AAV vectors in vitro and in vivo.
Zhong L; Chen L; Li Y; Qing K; Weigel-Kelley KA; Chan RJ; Yoder MC; Srivastava A
Mol Ther; 2004 Nov; 10(5):950-7. PubMed ID: 15509512
[TBL] [Abstract][Full Text] [Related]
12. Gene therapy for new bone formation using adeno-associated viral bone morphogenetic protein-2 vectors.
Chen Y; Luk KD; Cheung KM; Xu R; Lin MC; Lu WW; Leong JC; Kung HF
Gene Ther; 2003 Aug; 10(16):1345-53. PubMed ID: 12883531
[TBL] [Abstract][Full Text] [Related]
13. Recombinant adeno-associated viral vectors as therapeutic agents to treat neurological disorders.
Mandel RJ; Manfredsson FP; Foust KD; Rising A; Reimsnider S; Nash K; Burger C
Mol Ther; 2006 Mar; 13(3):463-83. PubMed ID: 16412695
[TBL] [Abstract][Full Text] [Related]
14. Improved cardiac gene transfer by transcriptional and transductional targeting of adeno-associated viral vectors.
Müller OJ; Leuchs B; Pleger ST; Grimm D; Franz WM; Katus HA; Kleinschmidt JA
Cardiovasc Res; 2006 Apr; 70(1):70-8. PubMed ID: 16448634
[TBL] [Abstract][Full Text] [Related]
15. Improved transduction of primary murine hepatocytes by recombinant adeno-associated virus 2 vectors in vivo.
Zhong L; Li W; Yang Z; Chen L; Li Y; Qing K; Weigel-Kelley KA; Yoder MC; Shou W; Srivastava A
Gene Ther; 2004 Jul; 11(14):1165-9. PubMed ID: 15164097
[TBL] [Abstract][Full Text] [Related]
16. Clinical gene therapy using recombinant adeno-associated virus vectors.
Mueller C; Flotte TR
Gene Ther; 2008 Jun; 15(11):858-63. PubMed ID: 18418415
[TBL] [Abstract][Full Text] [Related]
17. Differential internalization and nuclear uncoating of self-complementary adeno-associated virus pseudotype vectors as determinants of cardiac cell transduction.
Sipo I; Fechner H; Pinkert S; Suckau L; Wang X; Weger S; Poller W
Gene Ther; 2007 Sep; 14(18):1319-29. PubMed ID: 17611587
[TBL] [Abstract][Full Text] [Related]
18. Stable rAAV-mediated transduction of rod and cone photoreceptors in the canine retina.
Bainbridge JW; Mistry A; Schlichtenbrede FC; Smith A; Broderick C; De Alwis M; Georgiadis A; Taylor PM; Squires M; Sethi C; Charteris D; Thrasher AJ; Sargan D; Ali RR
Gene Ther; 2003 Aug; 10(16):1336-44. PubMed ID: 12883530
[TBL] [Abstract][Full Text] [Related]
19. Production of recombinant adeno-associated virus vectors using a packaging cell line and a hybrid recombinant adenovirus.
Liu XL; Clark KR; Johnson PR
Gene Ther; 1999 Feb; 6(2):293-9. PubMed ID: 10435114
[TBL] [Abstract][Full Text] [Related]
20. Transduction of ovarian cancer cells: a recombinant adeno-associated viral vector compared to an adenoviral vector.
Vermeij J; Zeinoun Z; Neyns B; Teugels E; Bourgain C; De Grève J
Br J Cancer; 2001 Nov; 85(10):1592-9. PubMed ID: 11720450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
